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different compartments of the yeasts, including intracellular.
Using chromatography and mass-spectrometry the steroids were
also found to undergo partial conversion into 3-O-acetates by S.
cerevisiae, but not Y. lipolytica, which was in accordance with
computational BLAST search of S. cerevisiae Atf2p homologues.
Also the compounds’ binding with mammalian STARD1 protein
were observed. Compound 2 is also promising as a Raman probe
due to alkyne insertion into its side chain. Basing on both the
results and Autodock Vina-aided docking simulations with vari-
ous sterol-binding proteins, e.g. STARD1 (3pl0), Osh4 (1zhw),
Osh1 (5wvr) and Npc1 (3gkj), we speculate about possibilities of
20-hydroxycholesterol-like compounds to affect yeast cells or
mammalian mitochondria as well as future perspectives of such
compounds synthesis and usage for studies of 20-oxysterol traf-
ficking and signaling. This work was supported by joint BRFFI
(X16P-065) - RFFI (16-54-00139) grant, Belarusian SPSI grant
20161380 and RSF grant 17-74-10053.
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Ganglioside GM1 has demonstrated to attenuate Parkinson Dis-
ease (PD) symptoms in clinical and preclinical trials. Neverthe-
less, the GM1 efficacy revealed in vitro is critically reduced
in vivo, because of the amphiphilic behavior that limits the pas-
sage across the blood brain barrier (BBB). In vitro and in vivo
experiments showed that GM1 exerts neurotrophic functions by
interacting with plasma membrane (PM) proteins throughout its
oligosaccharide portion (OligoGM1). Furthermore, OligoGM1
intravenously or subcutaneously injected into mice is absorbed
and taken up by different organs and tissues, including brain. In
order to take advantage of GM1 oligosaccharide properties and
to overcome GM1 pharmacological limitation, this study has
been aimed by the investigation of the OligoGM1 transport
through the BBB, by using a human in vitro model for human
brain-like endothelial cells (hBLEC). Ruled out the toxicity of
OligoGM1 on hBLEC, the OligoGM1 transport across the hBBB
has been analyzed, finding out a 20 fold higher rate than GM1
and a time and concentration dependence. In order to character-
ize the OligoGM1 passage, a direct evaluation of the OligoGM1
interaction with the ABC-transporters was carried on, leaving
out this way for OligoGM1 transport. Moreover, inverse- and
4°C-transport experiments were performed excluding the implica-
tion of the active transport for OligoGM1 passage across the
hBLEC, leading to consider the passive-paracellular route. Fur-
thermore, after the hBLEC transport, OligoGM1 maintained its
stability and capacity to induce neuritogenesis in the mouse neu-
roblastoma cells line Neuro2a. This preliminary study has
improved the knowledge about the GM1 pharmacological poten-
tial by proving that OligoGM1 can cross advantageously the
BBB, offering a new promising therapeutic strategy.
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In light of its neurotrophic and neuroprotective properties, GM1
ganglioside has been considered as a master regulator of the ner-
vous system. Recently, we demonstrated in a mouse neuroblas-
toma cell line N2a that the oligosaccharide portion of GM1
(OligoGM1) is responsible for the ability of GM1 to induce neu-
ritogenesis by the activation of the TrkA-MAPK pathway. This
means that the specific role of GM1 in neuronal differentiation is
determined by a direct interaction between its oligosaccharide
portion and specific proteins expressed on the plasma membrane.
In order to understand if the exogenous administration of Oli-
goGM1 and the resulting activation of TrkA pathway is able to
trigger crucial biochemical signaling, we performed a proteomic
analysis on N2a cells treated with 50 lM OligoGM1 for 24 h.
The analysis led to the identification and quantification of 744
proteins; 324 proteins were identified only in OligoGM1-treated
cells. Interestingly, the OligoGM1-only proteins are mainly
involved in biochemical mechanisms, many of which offer neuro-
protective potential reflecting the GM1 neuroprotective effect. To
confirm that the neuroprotective effect of GM1 is due to its
oligosaccharide portion, OligoGM1-treated N2a cells were
administered with MPTP for 48 h. We found that MPTP-induced
mortality was reduced by 50% in OligoGM1-treated cells respect
to untreated ones. Furthermore, we saw that the administration
to N2a cells of dichlorobenzamil (DCB), a potent inhibitor of the
Na+-Ca2+ antiporter, which results in elevating intracellular
Ca2+, is responsible for cell death after 24-h exposure. In pres-
ence of 50 lM OligoGM1 the DCB-cell mortality is definitely
reduced, suggesting that the modulation of Ca2+ flux might be
one mechanism in the neuroprotective effect due to exogenous
administration of OligoGM1. Our results suggest that the molec-
ular mechanisms underlying the neuroprotection effects induced
by GM1 depend on its oligosaccharide chain.
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Type II membrane proteins are inserted into endoplasmic reticu-
lum (ER) at the early stage of protein subcellular localization
due to the recognition of the signal-anchors by ER translocons.
However, the evidential transport mechanisms of transmembrane
protein localization from ER to the Golgi or plasma membrane
have not been elucidated. Understanding the mechanism of pro-
tein subcellular localization is believed to be crucial for control
of protein subcellular localization. In this study, to elucidate
transport mechanisms of transmembrane proteins, the amino acid
propensities around the signal-anchor and C-terminus regions
were calculated. The transmembrane protein dataset was classi-
fied into three groups: plasma membrane proteins, ER membrane
proteins and Golgi membrane proteins. Especially, the trans-
Golgi membrane protein dataset was extracted from the Golgi
group. The discrimination accuracy of each group was estimated
by the discrimination scores which were calculated by the posi-
tion-specific scoring matrix (PSSM) to evaluate whether the
transmembrane protein localization is determined by the
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